R Pichlmayr
Overview
Explore the profile of R Pichlmayr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
635
Citations
3575
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bannasch P, Jahn U, Hacker H, Su Q, Hoffmann W, Pichlmayr R, et al.
Int J Oncol
. 2011 May;
10(2):261-8.
PMID: 21533371
Foci of altered hepatocytes (FAH) including clear cell foci excessively storing glycogen (focal hepatic glycogenosis) are well known as preneoplastic lesions in animal models of hepatocarcinogenesis induced by chemical, physical...
2.
Gratz K, Jahne J, Hamann A, Piso P, Pichlmayr R, Hundeshagen H
Nuklearmedizin
. 2006 Oct;
36(8):276-81.
PMID: 17068878
Aim: Intraoperative peritoneal chemohyperthermia (IPCH) followed by one or more courses of closed intraperitoneal chemotherapy via peritonealdialysis-catheter (Zellermann) is a promising concept for treatment of peritoneal carcinomatosis. Methods: To prove...
3.
Lufft V, Dannenberg B, Schlitt H, Pichlmayr R, Brunkhorst R
Clin Nephrol
. 2004 May;
61(4):238-45.
PMID: 15125029
Background: The proportion of diabetics among patients requiring renal replacement therapy continues to increase in most western countries. The acceptance rate for renal transplantation varies among transplant centers and is...
4.
5.
Adam R, Cailliez V, Majno P, Karam V, McMaster P, Caine R, et al.
Lancet
. 2000 Sep;
356(9230):621-7.
PMID: 10968434
Background: No model exists for liver transplantation to estimate the mortality risk in a given patient, and no standard by which to assess performance in different centres. We investigated the...
6.
Raab R, Schlitt H, Oldhafer K, Bornscheuer A, Lang H, Pichlmayr R
Langenbecks Arch Surg
. 2000 Jun;
385(3):179-84.
PMID: 10857488
Some primary and secondary liver tumours are not absolutely irresectable, but cannot be resected using a conventional approach because of the limited warm ischaemia tolerance of the liver or poor...
7.
Oldhafer K, Lang H, Schlitt H, Hauss J, Raab R, Klempnauer J, et al.
Surgery
. 2000 May;
127(5):520-7.
PMID: 10819060
Background: Ex situ liver surgery allows liver resection and vascular reconstruction in patients who have liver tumors located at critical sites. Only a small series of studies about ex situ...
8.
Neumayer H, Paradis K, Korn A, Jean C, Fritsche L, Budde K, et al.
Br J Clin Pharmacol
. 1999 Dec;
48(5):694-703.
PMID: 10594471
Aims: To evaluate the tolerability of single oral SDZ RAD doses in stable renal transplant recipients and the pharmacokinetics of ascending SDZ RAD doses when coadministered with steady-state cyclosporin A...
9.
Schlitt H, Neipp M, Weimann A, Oldhafer K, Schmoll E, Boeker K, et al.
J Clin Oncol
. 1999 Aug;
17(1):324-31.
PMID: 10458250
Purpose: Tumor recurrence is the major limitation of long-term survival after liver transplantation for hepatocellular carcinoma (HCC) or fibrolamellar carcinoma (FLC). Understanding tumor-biologic characteristics is important for selection of patients...
10.
Oldhafer K, Bornscheuer A, Fruhauf N, Frerker M, Schlitt H, Ringe B, et al.
Transplantation
. 1999 Apr;
67(7):1024-8.
PMID: 10221488
Background: Early retransplantation is the therapy of choice in patients with initial graft nonfunction (INF). In rare cases the patients' conditions deteriorate dramatically with severe cardiovascular and/or pulmonary insufficiency while...